- Home
- MRUS vs AKR Comparison
MRUS vs AKR Comparison
Compare MRUS & AKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRUS
- AKR
- Stock Information
- Founded
- MRUS 2003
- AKR 1993
- Country
- MRUS Netherlands
- AKR United States
- Employees
- MRUS N/A
- AKR N/A
- Industry
- MRUS Biotechnology: Pharmaceutical Preparations
- AKR Real Estate Investment Trusts
- Sector
- MRUS Health Care
- AKR Real Estate
- Exchange
- MRUS Nasdaq
- AKR Nasdaq
- Market Cap
- MRUS 2.9B
- AKR 2.9B
- IPO Year
- MRUS 2016
- AKR 1993
- Fundamental
- Price
- MRUS $39.45
- AKR $22.65
- Analyst Decision
- MRUS Strong Buy
- AKR Buy
- Analyst Count
- MRUS 12
- AKR 4
- Target Price
- MRUS $87.92
- AKR $23.00
- AVG Volume (30 Days)
- MRUS 706.1K
- AKR 1.6M
- Earning Date
- MRUS 02-26-2025
- AKR 02-11-2025
- Dividend Yield
- MRUS N/A
- AKR 3.27%
- EPS Growth
- MRUS N/A
- AKR N/A
- EPS
- MRUS N/A
- AKR 0.10
- Revenue
- MRUS $35,932,000.00
- AKR $367,395,000.00
- Revenue This Year
- MRUS N/A
- AKR N/A
- Revenue Next Year
- MRUS $57.37
- AKR $7.14
- P/E Ratio
- MRUS N/A
- AKR $217.47
- Revenue Growth
- MRUS N/A
- AKR 7.51
- 52 Week Low
- MRUS $31.62
- AKR $16.10
- 52 Week High
- MRUS $61.61
- AKR $26.29
- Technical
- Relative Strength Index (RSI)
- MRUS 38.07
- AKR 38.10
- Support Level
- MRUS $38.52
- AKR $21.85
- Resistance Level
- MRUS $47.75
- AKR $24.26
- Average True Range (ATR)
- MRUS 2.05
- AKR 0.51
- MACD
- MRUS -0.17
- AKR -0.07
- Stochastic Oscillator
- MRUS 16.83
- AKR 32.99
About MRUS Merus N.V.
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.
About AKR Acadia Realty Trust
Acadia Realty Trust is a real estate investment trust that specializes in the operation, management, leasing, renovation, and acquisition of shopping centers and mixed-use properties with retail components. The company's portfolios are located primarily in metropolitan areas of the United States. The company operates through three segments: core portfolio, which consists primarily of high-quality retail properties located primarily in high-barrier-to-entry, densely-populated metropolitan areas with a long-term investment horizon and generates the majority of total revenue; funds, which comprises the funds launched by the trust; and structured financing, which consists of notes receivable and related interest income.